| USD millions | FY2022 | FY2023 | FY2024 | FY2025 | Trend | YoY |
|---|---|---|---|---|---|---|
| Revenue | 88.6 | 115.6 | 122.1 | 140.0 | +14.7% | |
| Cost of revenue | 62.7 | 86.0 | 82.8 | 135.1 | +63.2% | |
| Gross profit | 25.9 | 29.6 | 39.3 | 4.9 | −87.6% | |
| Research & development | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Selling, general & administrative | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Selling & marketing | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Operating expenses | 0.0 | 0.0 | 0.0 | (30.5) | — | |
| Operating income | 18.1 | 21.2 | 29.7 | 35.4 | +19.2% | |
| Interest expense | 0.0 | 0.0 | 0.0 | 16.2 | — | |
| Interest income | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Other income / expense | (1.1) | (5.4) | (12.3) | (16.0) | −29.9% | |
| Pre-tax income | 16.9 | 15.7 | 17.3 | 19.3 | +11.5% | |
| Income tax | 1.0 | 0.6 | 0.6 | 0.4 | −24.1% | |
| Net income | 16.0 | 15.2 | 16.8 | 18.9 | +12.8% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| EPS, basic (per share) | 0.53 | 0.51 | 0.56 | 0.63 | +12.5% | |
| EPS, diluted (per share) | 0.53 | 0.51 | 0.56 | 0.63 | +12.5% | |
| EBITDA | 45.4 | 45.4 | 59.7 | 73.2 | +22.6% | |
| Depreciation & amortization | 27.3 | 24.2 | 30.0 | 37.6 | +25.5% | |
| Weighted average shares (shares) | 30,000,000 | 30,000,000 | 30,000,000 | 29,973,000 | −0.1% | |
| Weighted average diluted shares (shares) | 30,000,000 | 30,000,000 | 30,000,000 | 29,973,000 | −0.1% | |
| Gross margin | 29.2% | 25.6% | 32.2% | 3.5% | −28.7 pts | |
| Operating margin | 20.4% | 18.3% | 24.3% | 25.3% | +1.0 pts | |
| Net margin | 18.0% | 13.1% | 13.7% | 13.5% | −0.2 pts |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
Statements are reported in USD; the shares trade in SAR.
